FDA OKs Empagliflozin for Children With Type 2 Diabetes FDA OKs Empagliflozin for Children With Type 2 Diabetes
Both Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin) were approved for children aged 10 years and older.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
More News: Children | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Empagliflozin | Endocrinology | Fortamet | Jardiance | Metformin